Experimental procedures
Compound 4. To a solution of 3 (9.20 g, 24.4 mmol) in pyridine (139 mL) was added acetic anhydride (69.3 mL, 0.733 mol). The reaction was stirred for 16 h and concentrated in vacuo. The crude product was then purified by silica gel chromatography using a gradient of 2:1 hexanes:ethyl acetate to 1:1 hexanes:ethyl acetate to afford 11.4 g (93%) of a yellow oil as a mixture of anomers (2:3 α:β). 1 H NMR of β-anomer (500 MHz, CDCl 3 ): δ 6.56 (d, 1H, J = 9.5), 6 .03 (s, 1H), 5.26 (app t, 1H, J = 9.9), 5.05 (dd, 1H, J = 3.9, 10.0), 4.60 (d, 1H, J = 9.6), 4 .06 (m, 2H), 3.63-3.85 (m, 3H), 2.00-2.18 (m, 9H), 0.91 (s, 9H), 0.06 (app d, 6H, J = 9.1). 13 Compound 5. Acetic acid (14 mL) was added to a solution of 4 (1.10 g, 2.20 mmol) in a 1:1 solution of THF and H 2 O (9.6 mL). The resulting mixture was stirred for 24 h. The reaction was neutralized with sat. NaHCO 3 , and the crude product was extracted with ethyl acetate (3 x 25 mL). The organic layers were pooled, washed with brine (1 x 75 mL), dried with Na 2 SO 4 , filtered, and concentrated in vacuo. Silica gel chromatography of the crude product, eluting with a gradient of 1:2 hexanes:ethyl acetate to 1:3 hexanes:ethyl acetate, yielded 800 mg (93%) of a white solid as a mixture of anomers (2:1 α:β). 1 3 (963 mg, 1.75 mmol) were dried by azeotroping with toluene (3 x 10 mL). Pyridine (12 mL) was added, followed by dimethylaminopyridine (214 mg, 1.75 mmol). The resulting mixture was stirred for 18 h at 40 °C. The reaction was concentrated, and the residue was passed through a plug of silica gel using 9:1 toluene:acetone to elute. The crude product was concentrated to afford a white solid that was dissolved in CH 2 Cl 2 (3 mL). TFA (1 mL) was added dropwise. The reaction was stirred for 30 min, diluted with toluene (10 mL), and concentrated in vacuo. The residual TFA was removed from the crude residue by azeotroping with toluene (3 x 10 mL). The crude product was then dissolved in 1:1 ddH 2 O:CH 3 , precipitated with methyl tertbutyl ether, and the crude product was dried and used without further purification. The crude peptide (308 mg, 0.450 mmol) was dissolved in DMF (4.4 mL), and TEA (0.0823 mL, 0.541 mmol) was added, followed by di-tert-butyldicarbonate (118 mg, 0.541 mmol). The resulting mixture was stirred for 29 h and concentrated in vacuo. The crude product was purified by reversed-phase HPLC using a C18 column (80:20 ddH 2 O:CH 3 Compound 1. TFA (0.25 mL) was added dropwise to a solution of 9 (10.7 mg, 0.0730 mmol) in CH 3 CN (0.75 mL). The resulting mixture was stirred for 2 h, and the reaction was then diluted S4 with toluene (10 mL). The reaction mixture was concentrated in vacuo, and residual TFA was removed by azeotroping with toluene (3 x 10 mL). The crude product was purified by reversedphase HPLC using a C18 column (75:25 ddH 2 O:CH 3 
PSA activity assay.
Activity of PSA and heat-killed (HK) PSA (50 μg/mL) were verified according to a previously established protocol 5 using a colorimetric substrate (MeO-Suc-Arg-Pro-Tyr-PNA·TFA, 500 μM) in 50 mM Tris, 0.1 M NaCl, pH 7.8. The enzymatic reactions were incubated at 37 °C and monitored at 405 nm for release of p-nitroanilide every 10 min for 15 h. Buffer only and buffer with substrate were used as negative controls.
In vitro enzymatic reactions.
Compound 1 (500 μM) was incubated with PSA (50 μg/mL), no enzyme, or HK PSA (50 μg/mL) in 50 mM Tris, 0.1 M NaCl, pH 7.8, for 24 h at 37 °C. The samples were filtered with Microcon Ultracel YM-10 filter devices (10,000 MWCO) by centrifugation (10,621 x g for 20 min) to remove the protein. The cellulose membrane was rinsed (1 x 50 μL ddH 2 O), and the sample was centrifuged again (10,621 x g for 10 min). The wash step was repeated twice. The filtrates were then analyzed by reversed-phase HPLC using a C18 analytical column (100:0 ddH 2 O:CH 3 CN + 0.1 % TFA to 60:40 ddH 2 O:CH 3 CN + 0.1% TFA over 60 min), monitoring at 210 nm, and by mass spectrometry.
Cell culture.
Chinese hamster ovary (CHO) cells were cultured in Ham's F-12 media supplemented with 10% FBS, 100 units/mL penicillin and 100 μg/mL streptomycin. PC-3 cells were cultured in RPMI-1640 supplemented with 10% FBS, 100 units/mL penicillin and 100 μg/mL streptomycin. The cells were maintained at 37 °C and 5% CO 2 in a water-saturated incubator and counted using a hemocytometer. Cell densities were maintained between 1 x 10 5 and 2 x 10 6 cells per mL.
Metabolism of Ac 3 ManNAz by CHO and PC-3 cells and analysis by flow cytometry.
CHO or PC-3 cells were seeded in 12-well tissue culture plates in 1 mL media and grown until 80-90% confluency. The media was aspirated, and the cells were washed with OptiMEM I (3 x 1 mL). The cells were then treated with OptiMEM I (0.4 mL) containing Ac 3 ManNAz (0-100 μM). (For the experiment shown in Figure S1B , the cells were treated with Ac 3 ManNAz (0-100 μM) in their respective full media.) The cells were incubated for 0-12 h, washed with PBS + 1% FBS (FACS buffer) (3 x 1 mL), and then lifted by treatment with 1 mM EDTA in PBS (0.65 mL) for 20-40 min. The cells were then transferred to a 96-well V-bottom plate and pelleted by centrifugation (2536 x g for 3 min). The supernatants were decanted, and the cells were resuspended with FACS buffer (0.2 mL). The cells were pelleted again and after discarding the supernatant, they were resuspended with DIFO-biotin (100 μM from a 1 mM stock in 12% S5 DMF/PBS) in FACS buffer (0.1 mL) and incubated for 2 h at 37 °C. After the labeling reaction, the cells were washed with FACS buffer as described above (3 x 0.2 mL) and resuspended in 0.1 mL of FACS buffer containing FITC-avidin (1:200 dilution of a 1 mg/mL stock). The cells were incubated for 15 min on ice in the dark. The cells were washed once with FACS buffer (0.2 mL), stained with FITC-avidin for a second time, and washed with FACS buffer (3 x 0.2 mL). The cells were then resuspended in FACS buffer (0.4 mL) for analysis by flow cytometry.
Cell-selective labeling of CHO and PC-3 cell-surface glycans and cell viability assay.
CHO or PC-3 cells were seeded in 12-well tissue culture plates in 1 mL media and grown until 80-90% confluency. At this point, the media was aspirated, and the cells were washed with OptiMEM I (3 x 1 mL) . The cells were then treated with OptiMEM I (0.4 mL) containing 1 (0-100 μM) and either PSA (0-50 μg/mL), no enzyme, or HK PSA (50 μg/mL). The cells were incubated for 12 h at 37 °C. Following incubation, the media was removed, and the cells were washed with PBS (3 x 1 mL). The cells were lifted by incubation with 1 mM EDTA in PBS (0.65 mL) for 20 min. The cells were then transferred to a 96-well V-bottom plate, labeled with DIFO-biotin, followed by FITC-avidin, and prepared for flow cytometry analysis as described above.
For the experiment shown in Figure S4 , the cells were washed with FACS buffer (1 x 0.2 mL) and then PBS (2 x 0.2 mL) after the second FITC-avidin staining. Prior to flow cytometry analysis, the cells were resuspended in 1X annexin binding buffer (prepared according to the manufacturer's protocol) containing annexin V-phycoerythrin (0.1 mL) and incubated for 15 min at rt in the dark. Additional 1X binding buffer (0.3 mL) was added, and the samples were analyzed by flow cytometry.
Imaging of cells by fluorescence microscopy.
CHO cells were seeded at a density of 1 x 10 5 cells per mL on slides mounted with 8tissue culture wells in 0.4 mL media. After 2 d, the cells were washed with OptiMEM I (3 x 0.5 mL) and then treated with 1 (100 μM) and either PSA or HK PSA (50 μg/mL) in OptiMEM I (0.2 mL). The cells were incubated for 12 h at 37 °C. The cells were then washed with media (3 x 0.5 mL) and incubated with DIFO-biotin (100 μM) in media (0.125 mL) for 2 h at 37 °C. The cells were washed with FACS buffer (3 x 0.5 mL) and then labeled with a quantum dot 605streptavidin conjugate (10 nM from a 1 μM stock in borate buffer, pH 8.3) in FACS buffer (0.1 mL) for 15 min at rt. The cells were washed with FACS buffer (3 x 0.5 mL) and stained with Hoechst 33342 (0.1 mL of a 1:1000 dilution from a 1 mg/mL DMSO stock) for 2 min in the dark. The cells were washed twice with media (0.5 mL) and imaged in media (0.2 mL). The images shown are maximum intensity z-projections of three z-planes acquired using a 63X objective.
Supplemental data
Scheme S1. Synthesis of 1 Figure S1C indicate that Ac 3 ManNAz is taken up and metabolized to generate detectable levels of cell-surface azido glycans as early as 30 min after the treatment had commenced. In considering whether the caged azidosugar strategy might be feasible for in vivo imaging of PSAexpressing tissues, we noted that protease-activatable probes similar to the one that we designed persist in the vicinity of the target tissue in vivo for up to 24 h after delivery of the probe due to the formation of a concentration gradient surrounding the tumor. [6] [7] [8] [9] Thus, while diffusion of Ac 3 ManNAz away from the target tissue after uncaging by PSA would likely occur in vivo, we do not expect it to be problematic because the enzyme would be constantly turning over substrate such that the uncaged probe would be found at a higher concentration near the target cells for many hours. In our situation, higher levels of uncaged Ac 3 ManNAz around the target tissue would result in higher levels of cell uptake compared to the surrounding tissue. Therefore, we believe that the data shown in Figure S1C demonstrates that diffusion is not problematic for implementation of the caged azidosugar strategy in vivo. Figure S2 . Flow cytometry analysis of CHO cells treated with 1 and PSA. CHO cells were incubated with or without 1 (25 μM) and PSA (0-50 μg/mL) for 12 h at 37 °C. The samples were then labeled with DIFO-biotin (100 μM) for 2 h at 37 °C, followed by FITC-avidin, and analyzed by flow cytometry. Error bars represent the standard deviation of the average MFI from three replicate samples. Figure S3 . Flow cytometry analysis of PC-3 cells treated with 1 and PSA. PC-3 cells were incubated with 1 (100 μM) and either no enzyme (-), HK PSA (50 μg/mL, HK), or PSA (50 μg/mL, +), for 12 h at 37 °C. The samples were then labeled with DIFO-biotin (100 μM) for 2 h at 37 °C, followed by FITC-avidin, and analyzed by flow cytometry. Error bars represent the standard deviation of the average MFI from three replicate samples. Figure S4 . Cell viability assay. CHO cells were incubated with 1 (0-100 μM) and either no enzyme (-), PSA (50 μg/mL, +), or HK PSA (50 μg/mL, HK), for 12 h at 37 °C. The samples were then labeled with DIFO-biotin (100 μM) for 2 h at 37 °C, followed by FITC-avidin and annexin V-phycoerythrin, and analyzed by flow cytometry. Percent live cells represent cells that stain weakly with annexin V. Error bars represent the standard deviation of the average % live cells for three replicate samples.
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